Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||- / 1||- / -|
Administered by: Other Purchased by: ??
Symptoms: Nasopharyngitis, Pyrexia, Vomiting
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Medical History/Concurrent Conditions: Lactation decreased
Diagnostic Lab Data:
CDC 'Split Type': GBPFIZER INC2021657801
Write-up: fever/cold and hot fever; cold and hot fever; Vomiting; This is a spontaneous report from a contactable consumer (patient) received from the Regulatory Agency. The regulatory authority report number is GB-MHRA-WEBCOVID-202106041325472710-VB615, Safety Report Unique Identifier GB-MHRA-ADR 25420531. A 32-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 03Jun2021 (Lot number was not reported) as 1st dose, single at the age of 32-year-old for COVID-19 immunisation. Medical history included lactation decreased. Patient has not had symptoms associated with COVID-19. Not had a COVID-19 test. Patient is not enrolled in clinical trial. Patient is not currently breastfeeding. The patient''s concomitant medications were not reported. Patient had a couple of alcoholic drinks after receiving the vaccine, and have been vomiting all morning, with cold and hot fever on 03Jun2021. Patient has not tested positive for COVID-19 since having the vaccine. The seriousness was reported as medically significant. The outcome of event vomiting was recovering. The outcome of other event was unknown. No follow-up attempts are possible, information about batch number cannot be obtained.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166